Emergence and Possible Transmission of Amantadine-resistant Viruses during Nursing Home Outbreaks of Influenza A (H3N2)
Identifieur interne : 002028 ( Main/Exploration ); précédent : 002027; suivant : 002029Emergence and Possible Transmission of Amantadine-resistant Viruses during Nursing Home Outbreaks of Influenza A (H3N2)
Auteurs : Eric E. Mast [États-Unis] ; Maurice W. Harmon [États-Unis] ; Stefan Gravenstein [États-Unis] ; Si Ping Wu [États-Unis] ; Nancy H. Arden [États-Unis] ; Richard Circo [États-Unis] ; Gail Tyszka [États-Unis] ; Alan P. Kendal [États-Unis] ; Jeffrey P. Davis [États-Unis]Source :
- American Journal of Epidemiology [ 0002-9262 ] ; 1991.
Abstract
Outbreaks of influenza A (H3N2, A/Shanghai/11/87-like) occurred in two partially (60% and 79%) vaccinated nursing home populations in January i988. A retrospective cohort study using chart review was designed to assess the effectiveness of influenza vaccination and amantadine prophylaxis (100 mg per day) in controlling the outbreaks and to determine the amantadine susceptibility of influenza viruses isolated from casepatients. The point estimate of vaccine efficacy in preventing influenza-like illness was −33% (95% confidence interval −115% to 18%). However, 9% of vaccinated case-patients died within 14 days after onset of influenza-like illness compared with 26% of unvaccinated case-patients (relative risk = 0.4, 95% confidence interval 0.1–1.0). There was no signfficant difference in illness severity among case-patients who became ill before amantadine prophylaxis was started (n = 84) compared with those who became ill while taking amantadine (n = 34). Four virus isolates obtained before amantadine prophylaxis was started demonstrated 52–68% inhibition by 1 μg/ml of amantadine; by comparison, six isolates (resistant viruses) obtained from residents who became ill while taking amantadine demonstrated 1–18% inhibition. The resistant viruses had four different RNA sequences in the gene coding for the M2 protein transmembrane region. Three resistant viruses with identical RNA sequences were isolated from residents living in contiguous rooms who had onset of signs and symptoms during a 6-day interval. Further studies are needed to determine how frequently and under what circumstances resistant viruses occur when antiviral agents are used to control institutional influenza A outbreaks. Strategies for antiviral agent administration that limit the emergence and transmission of resistant virus strains may be needed.
Url:
DOI: 10.1093/oxfordjournals.aje.a116184
Affiliations:
Links toward previous steps (curation, corpus...)
- to stream Istex, to step Corpus: 001666
- to stream Istex, to step Curation: 001666
- to stream Istex, to step Checkpoint: 000D70
- to stream Main, to step Merge: 002127
- to stream Main, to step Curation: 002028
Le document en format XML
<record><TEI wicri:istexFullTextTei="biblStruct"><teiHeader><fileDesc><titleStmt><title>Emergence and Possible Transmission of Amantadine-resistant Viruses during Nursing Home Outbreaks of Influenza A (H3N2)</title><author><name sortKey="Mast, Eric E" sort="Mast, Eric E" uniqKey="Mast E" first="Eric E." last="Mast">Eric E. Mast</name></author><author><name sortKey="Harmon, Maurice W" sort="Harmon, Maurice W" uniqKey="Harmon M" first="Maurice W." last="Harmon">Maurice W. Harmon</name></author><author><name sortKey="Gravenstein, Stefan" sort="Gravenstein, Stefan" uniqKey="Gravenstein S" first="Stefan" last="Gravenstein">Stefan Gravenstein</name></author><author><name sortKey="Wu, Si Ping" sort="Wu, Si Ping" uniqKey="Wu S" first="Si Ping" last="Wu">Si Ping Wu</name></author><author><name sortKey="Arden, Nancy H" sort="Arden, Nancy H" uniqKey="Arden N" first="Nancy H." last="Arden">Nancy H. Arden</name></author><author><name sortKey="Circo, Richard" sort="Circo, Richard" uniqKey="Circo R" first="Richard" last="Circo">Richard Circo</name></author><author><name sortKey="Tyszka, Gail" sort="Tyszka, Gail" uniqKey="Tyszka G" first="Gail" last="Tyszka">Gail Tyszka</name></author><author><name sortKey="Kendal, Alan P" sort="Kendal, Alan P" uniqKey="Kendal A" first="Alan P." last="Kendal">Alan P. Kendal</name></author><author><name sortKey="Davis, Jeffrey P" sort="Davis, Jeffrey P" uniqKey="Davis J" first="Jeffrey P." last="Davis">Jeffrey P. Davis</name></author></titleStmt><publicationStmt><idno type="wicri:source">ISTEX</idno><idno type="RBID">ISTEX:169AA4941847029D71AD0446205E4D9D3D9EA4C6</idno><date when="1991" year="1991">1991</date><idno type="doi">10.1093/oxfordjournals.aje.a116184</idno><idno type="url">https://api.istex.fr/ark:/67375/HXZ-QV7QTLT7-3/fulltext.pdf</idno><idno type="wicri:Area/Istex/Corpus">001666</idno><idno type="wicri:explorRef" wicri:stream="Istex" wicri:step="Corpus" wicri:corpus="ISTEX">001666</idno><idno type="wicri:Area/Istex/Curation">001666</idno><idno type="wicri:Area/Istex/Checkpoint">000D70</idno><idno type="wicri:explorRef" wicri:stream="Istex" wicri:step="Checkpoint">000D70</idno><idno type="wicri:doubleKey">0002-9262:1991:Mast E:emergence:and:possible</idno><idno type="wicri:Area/Main/Merge">002127</idno><idno type="wicri:Area/Main/Curation">002028</idno><idno type="wicri:Area/Main/Exploration">002028</idno></publicationStmt><sourceDesc><biblStruct><analytic><title level="a" type="main" xml:lang="en">Emergence and Possible Transmission of Amantadine-resistant Viruses during Nursing Home Outbreaks of Influenza A (H3N2)</title><author><name sortKey="Mast, Eric E" sort="Mast, Eric E" uniqKey="Mast E" first="Eric E." last="Mast">Eric E. Mast</name><affiliation wicri:level="2"><country xml:lang="fr">États-Unis</country><placeName><region type="state">Wisconsin</region></placeName><wicri:cityArea>Bureau of Community Health and Prevention, Wisconsin Division of Health Madison</wicri:cityArea></affiliation><affiliation wicri:level="2"><country xml:lang="fr">États-Unis</country><placeName><region type="state">Géorgie (États-Unis)</region></placeName><wicri:cityArea>Division of Field Services, Epidemiology Program Office, Centers for Disease Control Atlanta</wicri:cityArea></affiliation><affiliation wicri:level="2"><country xml:lang="fr">États-Unis</country><placeName><region type="state">Géorgie (États-Unis)</region></placeName><wicri:cityArea>Reprint requests to Dr. Eric E. Mast, Mailstop A33, Division of Viral and Rickettsial Diseases, Centers for Disease Control, Atlanta</wicri:cityArea></affiliation></author><author><name sortKey="Harmon, Maurice W" sort="Harmon, Maurice W" uniqKey="Harmon M" first="Maurice W." last="Harmon">Maurice W. Harmon</name><affiliation wicri:level="2"><country xml:lang="fr">États-Unis</country><placeName><region type="state">Géorgie (États-Unis)</region></placeName><wicri:cityArea>Influenza Branch, Division of Viral Diseases, Center for Infectious Diseases, Centers for Disease Control Atlanta</wicri:cityArea></affiliation></author><author><name sortKey="Gravenstein, Stefan" sort="Gravenstein, Stefan" uniqKey="Gravenstein S" first="Stefan" last="Gravenstein">Stefan Gravenstein</name><affiliation wicri:level="2"><country xml:lang="fr">États-Unis</country><placeName><region type="state">Wisconsin</region></placeName><wicri:cityArea>Department of Medicine, University of Wisconsin School of Medicine Madison</wicri:cityArea></affiliation></author><author><name sortKey="Wu, Si Ping" sort="Wu, Si Ping" uniqKey="Wu S" first="Si Ping" last="Wu">Si Ping Wu</name><affiliation wicri:level="2"><country xml:lang="fr">États-Unis</country><placeName><region type="state">Géorgie (États-Unis)</region></placeName><wicri:cityArea>Influenza Branch, Division of Viral Diseases, Center for Infectious Diseases, Centers for Disease Control Atlanta</wicri:cityArea></affiliation></author><author><name sortKey="Arden, Nancy H" sort="Arden, Nancy H" uniqKey="Arden N" first="Nancy H." last="Arden">Nancy H. Arden</name><affiliation wicri:level="2"><country xml:lang="fr">États-Unis</country><placeName><region type="state">Géorgie (États-Unis)</region></placeName><wicri:cityArea>Influenza Branch, Division of Viral Diseases, Center for Infectious Diseases, Centers for Disease Control Atlanta</wicri:cityArea></affiliation></author><author><name sortKey="Circo, Richard" sort="Circo, Richard" uniqKey="Circo R" first="Richard" last="Circo">Richard Circo</name><affiliation wicri:level="2"><country xml:lang="fr">États-Unis</country><placeName><region type="state">Wisconsin</region></placeName><wicri:cityArea>Wisconsin State Laboratory of Hygiene Madison</wicri:cityArea></affiliation></author><author><name sortKey="Tyszka, Gail" sort="Tyszka, Gail" uniqKey="Tyszka G" first="Gail" last="Tyszka">Gail Tyszka</name><affiliation wicri:level="2"><country xml:lang="fr">États-Unis</country><placeName><region type="state">Wisconsin</region></placeName><wicri:cityArea>Sheboygan County Health Department Sheboygan</wicri:cityArea></affiliation></author><author><name sortKey="Kendal, Alan P" sort="Kendal, Alan P" uniqKey="Kendal A" first="Alan P." last="Kendal">Alan P. Kendal</name><affiliation wicri:level="2"><country xml:lang="fr">États-Unis</country><placeName><region type="state">Géorgie (États-Unis)</region></placeName><wicri:cityArea>Influenza Branch, Division of Viral Diseases, Center for Infectious Diseases, Centers for Disease Control Atlanta</wicri:cityArea></affiliation></author><author><name sortKey="Davis, Jeffrey P" sort="Davis, Jeffrey P" uniqKey="Davis J" first="Jeffrey P." last="Davis">Jeffrey P. Davis</name><affiliation wicri:level="2"><country xml:lang="fr">États-Unis</country><placeName><region type="state">Wisconsin</region></placeName><wicri:cityArea>Bureau of Community Health and Prevention, Wisconsin Division of Health Madison</wicri:cityArea></affiliation></author></analytic><monogr></monogr><series><title level="j" type="main">American Journal of Epidemiology</title><idno type="eISSN">1476-6256</idno><idno type="ISSN">0002-9262</idno><imprint><publisher>Oxford University Press</publisher><date when="1991-11-01">1991</date><biblScope unit="vol">134</biblScope><biblScope unit="issue">9</biblScope><biblScope unit="page" from="988">988</biblScope><biblScope unit="page" to="997">997</biblScope></imprint><idno type="ISSN">0002-9262</idno></series></biblStruct></sourceDesc><seriesStmt><idno type="ISSN">0002-9262</idno></seriesStmt></fileDesc><profileDesc><textClass></textClass></profileDesc></teiHeader><front><div type="abstract">Outbreaks of influenza A (H3N2, A/Shanghai/11/87-like) occurred in two partially (60% and 79%) vaccinated nursing home populations in January i988. A retrospective cohort study using chart review was designed to assess the effectiveness of influenza vaccination and amantadine prophylaxis (100 mg per day) in controlling the outbreaks and to determine the amantadine susceptibility of influenza viruses isolated from casepatients. The point estimate of vaccine efficacy in preventing influenza-like illness was −33% (95% confidence interval −115% to 18%). However, 9% of vaccinated case-patients died within 14 days after onset of influenza-like illness compared with 26% of unvaccinated case-patients (relative risk = 0.4, 95% confidence interval 0.1–1.0). There was no signfficant difference in illness severity among case-patients who became ill before amantadine prophylaxis was started (n = 84) compared with those who became ill while taking amantadine (n = 34). Four virus isolates obtained before amantadine prophylaxis was started demonstrated 52–68% inhibition by 1 μg/ml of amantadine; by comparison, six isolates (resistant viruses) obtained from residents who became ill while taking amantadine demonstrated 1–18% inhibition. The resistant viruses had four different RNA sequences in the gene coding for the M2 protein transmembrane region. Three resistant viruses with identical RNA sequences were isolated from residents living in contiguous rooms who had onset of signs and symptoms during a 6-day interval. Further studies are needed to determine how frequently and under what circumstances resistant viruses occur when antiviral agents are used to control institutional influenza A outbreaks. Strategies for antiviral agent administration that limit the emergence and transmission of resistant virus strains may be needed.</div></front></TEI><affiliations><list><country><li>États-Unis</li></country><region><li>Géorgie (États-Unis)</li><li>Wisconsin</li></region></list><tree><country name="États-Unis"><region name="Wisconsin"><name sortKey="Mast, Eric E" sort="Mast, Eric E" uniqKey="Mast E" first="Eric E." last="Mast">Eric E. Mast</name></region><name sortKey="Arden, Nancy H" sort="Arden, Nancy H" uniqKey="Arden N" first="Nancy H." last="Arden">Nancy H. Arden</name><name sortKey="Circo, Richard" sort="Circo, Richard" uniqKey="Circo R" first="Richard" last="Circo">Richard Circo</name><name sortKey="Davis, Jeffrey P" sort="Davis, Jeffrey P" uniqKey="Davis J" first="Jeffrey P." last="Davis">Jeffrey P. Davis</name><name sortKey="Gravenstein, Stefan" sort="Gravenstein, Stefan" uniqKey="Gravenstein S" first="Stefan" last="Gravenstein">Stefan Gravenstein</name><name sortKey="Harmon, Maurice W" sort="Harmon, Maurice W" uniqKey="Harmon M" first="Maurice W." last="Harmon">Maurice W. Harmon</name><name sortKey="Kendal, Alan P" sort="Kendal, Alan P" uniqKey="Kendal A" first="Alan P." last="Kendal">Alan P. Kendal</name><name sortKey="Mast, Eric E" sort="Mast, Eric E" uniqKey="Mast E" first="Eric E." last="Mast">Eric E. Mast</name><name sortKey="Mast, Eric E" sort="Mast, Eric E" uniqKey="Mast E" first="Eric E." last="Mast">Eric E. Mast</name><name sortKey="Tyszka, Gail" sort="Tyszka, Gail" uniqKey="Tyszka G" first="Gail" last="Tyszka">Gail Tyszka</name><name sortKey="Wu, Si Ping" sort="Wu, Si Ping" uniqKey="Wu S" first="Si Ping" last="Wu">Si Ping Wu</name></country></tree></affiliations></record>Pour manipuler ce document sous Unix (Dilib)
EXPLOR_STEP=$WICRI_ROOT/Sante/explor/H2N2V1/Data/Main/Exploration
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 002028 | SxmlIndent | more
Ou
HfdSelect -h $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd -nk 002028 | SxmlIndent | more
Pour mettre un lien sur cette page dans le réseau Wicri
{{Explor lien
|wiki= Sante
|area= H2N2V1
|flux= Main
|étape= Exploration
|type= RBID
|clé= ISTEX:169AA4941847029D71AD0446205E4D9D3D9EA4C6
|texte= Emergence and Possible Transmission of Amantadine-resistant Viruses during Nursing Home Outbreaks of Influenza A (H3N2)
}}
| This area was generated with Dilib version V0.6.33. |  |